RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy.

RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy.

Cervical cancer is one of the most common cancers in women worldwide, being high-risk group the HPV infected, the leading etiological factor. The raf kinase inhibitory protein (RKIP) has been associated with tumor progression and metastasis in several human neoplasms, however its role on cervical ca...

Full description

Bibliographic Details
Main Authors: Olga Martinho, Filipe Pinto, Sara Granja, Vera Miranda-Gonçalves, Marise A R Moreira, Luis F J Ribeiro, Celso di Loreto, Marsha R Rosner, Adhemar Longatto-Filho, Rui Manuel Reis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3602518?pdf=render

Internet

http://europepmc.org/articles/PMC3602518?pdf=render

Similar Items